Clinical Trials Data Retail Treatment 
NORML
MARCH 30, 2020
There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.
Project CBD
AUGUST 6, 2019
Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. None of the participants had been using any cannabinoid-based products prior to this study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
AUGUST 6, 2019
Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. None of the participants had been using any cannabinoid-based products prior to this study.
Project CBD
FEBRUARY 28, 2023
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales.
Cannabis Law Report
JULY 28, 2021
Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Advance to FDA IND-enabling studies to support human clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer.
Cannabis Law Report
JULY 29, 2021
Recreational Sales: Retail. In Newfoundland Heritage secured shelf space and shipped 27 new SKUs to the province and had re-orders from retailers a week later due to strong sell through. Additionally, Heritage will be launching CB4 Derma and CB4 Clear topical skincare products uniquely backed by product specific clinical trial data. “We
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).
Expert insights. Personalized for you.
290 
Let's personalize your content